The trial is sponsored by the NIAID, perhaps because GILD doesn't think the 6 weeks duration will be good enough or as you quoted, not commercial enough.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.